US 11246871
Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias
granted A61KA61K31/198A61K31/519
Quick answer
US patent 11246871 (Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias) held by Northwestern University expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/198, A61K31/519, A61K31/522, A61K31/5377